These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 2545861
1. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes. Marquis O, Robaut C, Cavero I. J Pharmacol Exp Ther; 1989 Jul; 250(1):293-300. PubMed ID: 2545861 [Abstract] [Full Text] [Related]
2. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes. Marquis O, Robaut C, Cavero I. J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350 [Abstract] [Full Text] [Related]
3. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Tahraoui L, Floch A, Mondot S, Cavero I. Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653 [Abstract] [Full Text] [Related]
4. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes. Floch A, Tahraoui L, Sedivy P, Cavero I. J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834 [Abstract] [Full Text] [Related]
5. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets. Tahraoui L, Floch A, Cavero I. J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995 [Abstract] [Full Text] [Related]
6. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors. Hwang SB, Lam MH, Hsu AH. Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468 [Abstract] [Full Text] [Related]
7. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor. Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC. J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114 [Abstract] [Full Text] [Related]
9. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. Herbert JM, Laplace MC, Cailleau C, Maffrand JP. J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255 [Abstract] [Full Text] [Related]
10. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. Nakashima S, Suganuma A, Sato M, Tohmatsu T, Nozawa Y. J Immunol; 1989 Aug 15; 143(4):1295-302. PubMed ID: 2545786 [Abstract] [Full Text] [Related]
11. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes]. Ukena D, Dent G, Chanez P, Barnes PJ, Sybrecht GW. Pneumologie; 1990 Feb 15; 44 Suppl 1():531-2. PubMed ID: 2164200 [Abstract] [Full Text] [Related]
12. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Ring PC, Seldon PM, Barnes PJ, Giembycz MA. Mol Pharmacol; 1993 Feb 15; 43(2):302-12. PubMed ID: 8381515 [Abstract] [Full Text] [Related]
13. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages. Chen J, Giri SN. J Pharmacol Exp Ther; 1997 Jun 15; 281(3):1047-58. PubMed ID: 9190835 [Abstract] [Full Text] [Related]
14. Characterization of platelet-activating factor receptors on canine T lymphocytes. Mangino MJ, Murphy MK, Weiss A, Anderson CB. J Immunol; 1993 Nov 15; 151(10):5310-8. PubMed ID: 8228226 [Abstract] [Full Text] [Related]
15. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. Hwang SB. J Lipid Mediat; 1990 Nov 15; 2(3-4):123-58. PubMed ID: 1966805 [Abstract] [Full Text] [Related]
16. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. Doebber TW, Wu MS, Biftu T. J Immunol; 1986 Jun 15; 136(12):4659-68. PubMed ID: 3011900 [Abstract] [Full Text] [Related]
17. Mechanism and regulation of neutrophil priming by platelet-activating factor. Gay JC. J Cell Physiol; 1993 Jul 15; 156(1):189-97. PubMed ID: 8391006 [Abstract] [Full Text] [Related]
18. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets. Morrison WJ, Shukla SD. J Pharmacol Exp Ther; 1989 Sep 15; 250(3):831-5. PubMed ID: 2550620 [Abstract] [Full Text] [Related]
19. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils. Svetlov S, Nigam S. Biochem Biophys Res Commun; 1993 Jan 15; 190(1):162-6. PubMed ID: 8380690 [Abstract] [Full Text] [Related]
20. High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes. Hwang SB. Eur J Pharmacol; 1991 Apr 17; 196(2):169-75. PubMed ID: 1651872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]